Søby S, Gothelf A, Gyldenkerne N, Bentzen J, Nowicka-Matus K, Tramm T, et al. Efficacy of nivolumab as second line treatment for recurrent or metastatic head and neck squamous cell carcinoma: a national DAHANCA cohort study. AO [Internet]. 2022 Aug. 3 [cited 2026 Jul. 18];61(8):972-8. Available from: https://medicaljournalssweden.se/actaoncologica/article/view/23747